This firm-fixed-price purchase order contract was awarded by the Bureau of Medicine and Surgery (a part of the U.S. Department of Defense) to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference standards based in Round Rock, Texas. The $76,775.55 contract does not have a set-aside designation.
Cerilliant has a history of providing essential reference materials and analytical standards to support various government healthcare, research, and testing initiatives across defense and civilian agencies. In this case, the company is supplying drug reference standards to the Defense Health Agency (DHA) for use in screening and confirmation testing of service member specimens, including post-mortem urine, blood, and tissue samples.
Additionally, Cerilliant holds several significant federal contract Indefinite Delivery Vehicles (IDVs) with the DHA, Army Medical Command, and Centers for Disease Control and Prevention (CDC), demonstrating its critical role in supplying these types of products to the government.